New Market Perspective
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

New Market Perspective

Politics

Hawley officially a yes on Dr. Oz after securing commitments on transgender, abortion issues

by admin April 1, 2025
April 1, 2025
Hawley officially a yes on Dr. Oz after securing commitments on transgender, abortion issues

: Sen. Josh Hawley, R-Mo., will vote to confirm President Donald Trump’s Centers for Medicare & Medicaid Services (CMS) nominee, Dr. Mehmet Oz, after securing commitments from him regarding transgender treatments for minors and abortion. 

‘On this basis, I will vote to confirm him. Now that I am confident that he has moved away from his previous positions, and he’s moved into alignment with the president, I feel comfortable voting for him,’ he told Fox News Digital in an exclusive interview on Monday. 

The senator revealed that Oz responded to his inquiries and disavowed his past stances on transgender treatments for minors and abortion in a series of posts on X earlier in the day. 

‘Dr. Oz has responded to my questions re: past support for trans treatments for minors & his criticism of right to life. Oz now disavows his previous support for trans surgeries & drugs for minor children. He pledges to ‘end chemical and surgical mutilation of children,’’ Hawley wrote on X on Monday. 

‘He also walks back past criticism of state pro-life laws, says he supports the Dobbs decision, and is ‘unequivocally pro-life.’ He vows to enforce conscience protections, end the abuse of [the Emergency Medical Treatment & Labor Act], and work to end funding for abortion providers,’ he continued. 

‘This was really a big shift of position for him,’ he explained, adding that he was ‘delighted’ by Oz’s responses. 

‘When it comes to the [transgender] issue and the life issue, those are non-negotiable for me, just as I believe they are for the president,’ the Missouri Republican explained. ‘I want to know that these people are 100% clear.’ 

‘Every member of the Trump administration is working from the same playbook, President Trump’s playbook, to restore commonsense policies and put an end to left-wing ideological nonsense afflicting our government,’ White House spokesman Kush Desai told Fox News Digital in a statement. ‘We look forward to the Senate’s swift confirmation of Dr. Oz so he can join the rest of our all-star team at HHS working to Make America Healthy Again by restoring common sense, transparency, and confidence in our healthcare apparatus.’

Earlier in the month, Hawley sent Oz a list of questions, specifically probing him on those issues. As of last week, Hawley said the nominee hadn’t responded, which the senator called ‘strange.’ 

Oz previously used his television show as a platform for people who supported and promoted transgender treatments, particularly for minors. Specifically, he hosted two transgender children on his show in 2010 in a segment titled, ‘Transgender Kids: Too Young to Decide?’ 

He also expressed concerns about state laws to limit abortion during a 2019 interview on the popular radio show ‘The Breakfast Club.’

It’s ‘a hard issue for everybody,’ he said at the time. 

And while on ‘a personal level,’ Oz didn’t like abortion, he also believed he should not ‘interfere with everyone else’s stuff,’ he said. 

Oz also opposed government jurisdiction on the subject of abortion when he ran for Senate in Pennsylvania as a Republican in 2022.

‘I don’t want the federal government involved with that at all,’ he claimed during a debate with now-Sen. John Fetterman, D-Pa. ‘I want women, doctors, local political leaders, letting the democracy that’s always allowed our nation to thrive, to put the best ideas forward, so states can decide for themselves.’

Hawley’s commitments from Oz are just the latest he’s received from Trump nominees as he considers them for confirmation. He previously got assurances from now-Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. on the same issues. 

When it came to now-leader of the Food and Drug Administration (FDA) Dr. Marty Makary, Hawley led a successful campaign to secure the resignation of a top lawyer with the FDA who previously argued in favor of abortion pill access in a high-profile case while in former President Joe Biden’s Department of Justice (DOJ). 

‘I just view my role for those I have to vote on — I want to know that these people are going to align with the president,’ Hawley said, noting that he believes Trump has ‘moved really fast [and] really strong’ on the issues. 

This post appeared first on FOX NEWS

0
FacebookTwitterGoogle +Pinterest
previous post
Trump quips he’d ‘love’ to run against Obama in hypothetical third-term presidency
next post
Finland to exit landmines treaty and hike defense spending given Russia threat, prime minister says

Related Posts

With 26 days until voting starts, ‘election season’...

August 11, 2024

Law enforcement brace as anti-Israel groups vow to...

August 15, 2024

Fetterman calls for bombing Iranian nuclear facilities: ‘Waste...

April 24, 2025

Outgoing WH official calls for US to bolster...

January 8, 2025

Blinken, US delegation drive from Paris to Brussels...

April 4, 2024

House advances Trump’s massive agenda bill after fiscal...

July 3, 2025

Biden running out of time to fulfill 2020...

February 28, 2024

Ilhan Omar claims no one has ‘attacked Americans,’...

June 19, 2025

Extremists rise in new Palestinian Authority government as...

April 7, 2024

Here’s what happened during President Donald Trump’s 6th...

March 1, 2025

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • At 90, the Dalai Lama braces for final showdown with Beijing: his reincarnation

      July 4, 2025
    • Russia becomes first nation to recognize Taliban government of Afghanistan since 2021 takeover

      July 4, 2025
    • Two arrested over ‘Chinese blessing scams’ targeting elderly Asian women in Australia

      July 4, 2025
    • Russia launches record number of drones at Ukraine after latest Trump-Putin phone call

      July 4, 2025
    • Elephant kills two female tourists from the UK and New Zealand in Zambian national park

      July 4, 2025
    • What is happening in South Korea? Seoul has caught the lovebug that nobody wants

      July 4, 2025

    Popular

    • 1

      Top 5 Junior Copper Stocks on the TSXV in 2023

      December 22, 2023
    • 2

      Canada Silver Cobalt Begins Drilling at Lowney-Lac Edouard in Quebec, Targeting Nickel-Copper-Cobalt Mineralization

      December 22, 2023
    • 3

      Crypto Market 2023 Year-End Review

      December 22, 2023
    • 4

      10 Top Oil-producing Countries (Updated 2024)

      October 19, 2024
    • 5

      Top 10 Uranium-producing Countries (Updated 2024)

      April 18, 2024
    • 6

      Powered by rain, this seed carrier could help reforest the most remote areas

      December 19, 2023
    • 7

      A troubling theory about traders profiting from Hamas’ attack on Israel drew much attention. Why it may not be so simple.

      December 13, 2023

    Categories

    • Business (1,398)
    • Investing (3,442)
    • Politics (4,517)
    • World (4,416)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: newmarketperspective.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 newmarketperspective.com | All Rights Reserved